FDA Inspection 776355 — ImpactLife
The FDA completed an inspection of ImpactLife on April 2, 2012 in Burlington, IA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- April 2, 2012
- Fiscal Year
- 2012
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Burlington, IA (United States)